Biotechnology in the US - Industry Market Research Report

Biotechnology in the US - Industry Market Research Report

  • July 2021 •
  • 53 pages •
  • Report ID: 199226 •
  • Format: PDF
Gene therapy: More than half of industry revenue is generated by sales of healthcare products


Biotechnology in the US
The Biotechnology industry is growing quickly, characterized by a multitude of product applications and a wide range of burgeoning markets. Growing demand for ethanol indicates the increasing importance of crop yields to agricultural customers, which have consistently demanded industry products over the past five years and will likely continue to do so over the five years to 2024. Similarly, more than half industry revenue is generated by sales of healthcare products, and the aging US population has driven demand for that segment’s products as a result of their growing medical needs. However, expired patents have created the opportunity for new entrants to develop new drugs with the possibility of being purchased by larger companies during the latter part of the period. Meanwhile, as competition from overseas falls over the next five years, industry revenue is projected to grow.

Companies in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.